NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,295.1
High1,322.9
Low1,295
Prev. Close1,290.6
Avg. Traded Price1,311.89
Volume16,36,057
MARKET DEPTH
Total bid1,94,576.00
Total ask1,76,671.00
| Orders | Qty | Bid |
|---|
| 1 | 8 | 1318.9 |
| 1 | 2 | 1318.7 |
| 2 | 201 | 1318.6 |
| 6 | 171 | 1318.5 |
| 8 | 179 | 1318.4 |
| Ask | Qty | Orders |
|---|
| 1319 | 5 | 1552 |
| 1319.2 | 1 | 1 |
| 1319.3 | 2 | 22 |
| 1319.4 | 5 | 218 |
| 1319.5 | 7 | 143 |
HIGH/LOW
LOW/HIGH
₹1,295.005 hours ago
₹1,322.90an hour ago
UTI Healthcare Fund-Reg(IDCW)
3Y Return+25.2%
NAV₹216.17
UTI Large & Mid Cap Fund-Reg(G)
3Y Return+24.2%
NAV₹175.93
UTI Multi Asset Allocation Fund-Reg(G)
UTI Aggressive Hybrid Fund-Reg(G)
3Y Return+18.7%
NAV₹400.98
UTI BSE Low Volatility Index Fund-Reg(G)
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
